BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Teva, MedinCell Schizophrenia Drug Delayed over FDA Concerns

  The FDA has issued a Complete Response Letter (CRL) for TV-46000/mdc-IRM (risperidone extended-release injectable suspension for subcutaneous use) to Teva Pharmaceuticals and MedinCell.

  April 20, 2022

   · 

  2 min read

   · 

  Jazmine Colatriano, M.S.
• 

  Drug Development

  Arcturus COVID-19 Vaccine Hits Mark in Phase III Trial

  Arcturus Therapeutics announced positive Phase III trial results for its mRNA vaccine candidate, ARCT-154, intended to prevent COVID-19 caused by the SARS-CoV-2 virus.

  April 20, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Policy

  Pharma Continues to Support Ukraine as War Rages On

  AbbVie, Novartis, Pfizer and other biopharma companies are ramping up support to Ukraine in the face of the continuing Russian invasion.

  April 20, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Elsevier Survey: Research Cooperation During COVID-19 Improved while Funding Lags

  The COVID-19 pandemic has seen increased collaboration in the research community while concerns about funding for overall research projects persist, according to Elsevier.

  April 20, 2022

   · 

  2 min read

   · 

  Geoff Herman
• 

  Drug Development

  FDA’s Cancer Advisory Committee to Evaluate Safety of PI3K inhibitors

  The U.S. FDA’s Oncologic Drugs Advisory Committee is holding a meeting on April 21, 2022, to discuss safety findings across the entire class of PI3K inhibitors for hematological cancers.

  April 20, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Job Trends

  Seagen and NovoCure to Open New Manufacturing and Learning Facilities

  Seagen, Inc. and NovoCure Ltd. have each announced plans to open new facilities in the coming years, expanding local employment opportunities and respective presences in the biotech industry.

  April 20, 2022

   · 

  2 min read

   · 

  Jazmine Coltriano, MS
• 

  Drug Development

  Global Roundup: BenevolentAI Takes on Dengue Fever in New Partnership

  Biopharma and life sciences organizations from across the globe provide updates on their businesses and pipelines.

  April 20, 2022

   · 

  6 min read

   · 

  Alex Keown
• 

  Drug Development

  Windtree is Bringing Patients Back from Cardiogenic Shock in Phase II

  New data unveiled by Windtree Therapeutics shows significant promise in heart failure patients who have deteriorated into cardiogenic shock.

  April 20, 2022

   · 

  4 min read

   · 

  Alex Keown
• 

  Business

  AbbVie Pulls Plug on Parkinson’s Partnership With BioArctic

  AbbVie has terminated its collaboration agreement with BioArctic in the development of alpha-synuclein antibodies for Parkinson’s Disease and other movement disorders.

  April 20, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, MS
• 

  Career Advice

  8 Pharma Jobs for Those Who Love to Travel

  Keep reading to take a look at some of the best pharma jobs for travelers. These jobs will allow you to see different parts of the world while working in an exciting and fast-paced industry.

  April 20, 2022

   · 

  5 min read

   · 

  Franklin Carpenter